ALTEROLA BIOTECH INC.

Q: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Jun 30 2024

FY: Mar 31 2024

FY: Mar 31 2024

Q: Dec 31 2023

Q: Dec 31 2023

Q: Dec 31 2023

Q: Sep 30 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Jun 30 2023

FY: Mar 31 2023

FY: Mar 31 2023

Q: Dec 31 2022

Q: Sep 30 2022

Q: Sep 30 2022

Entry into a Material Definitive Agreement

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

1.01,2.03,9.01

3.02,4.01,9.01

5.02

1.01,9.01

5.02

1.01,5.02

1.01,8.01,9.01

8.01,9.01

5.02,8.01,9.01

5.02

5.02

1.01,2.01,9.01

5.02,9.01

5.02

1.01,2.01,3.02,5.01,5.06,9.01

5.03

1.01,9.01

4.01,9.01

No description available

Notice of Effectiveness

Registration (IPO) statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration (IPO) statement under Securities Act of 1933

Notice of Effectiveness

Registration (IPO) statement under Securities Act of 1933

Bright Green Corp

Bright Green Corp

none

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC